Autonomix director awarded 13,000 restricted shares

A director of Autonomix Medical (AMIX) received a 13,000-share restricted stock award that will vest one year from its September 3, 2026 issuance.

Rhea-AI Filing Summary

Autonomix Medical, Inc. (symbol: AMIX) is the issuer of record for a Form 4 filing submitted to the SEC. KLEMP WALTER V reported acquisition or exercise transactions in this Form 4 filing.

Autonomix Medical, Inc. (AMIX) reported that director Walter V. Klemp received a grant of 13,000 shares of Common Stock as a restricted stock award on September 3, 2026. Following this equity award, he holds 20,118 shares directly, with the award vesting one year from September 3, 2026.

Insider Trade Summary

Grant/Award: 13,000 shares

Grant/Award 1 txn

Insider KLEMP WALTER V

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	13,000	--	--

Holdings After Transaction: Common Stock — 20,118 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

Key Figures

Restricted stock award: 13,000 shares Shares owned after transaction: 20,118 shares Vesting period: 1 year +1 more

4 metrics

Restricted stock award 13,000 shares Grant of Common Stock to director on September 3, 2026

Shares owned after transaction 20,118 shares Direct ownership by Walter V. Klemp following the award

Vesting period 1 year Restricted stock award vesting one-year from September 3, 2026

Transaction date September 3, 2026 Date of restricted stock award grant

Key Terms

restricted stock award, Common Stock, Rule 10b5-1

3 terms

restricted stock award financial

"Represents restricted stock award vesting one-year from the date of issuance"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Common Stock financial

"Represents restricted stock award in shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Rule 10b5-1 regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AMIX report for Walter V. Klemp?

Autonomix Medical (AMIX) reported that director Walter V. Klemp received a grant of 13,000 shares of Common Stock as a restricted stock award on September 3, 2026. The grant is classified as an acquisition, not a market purchase.

How many AMIX shares does Walter V. Klemp hold after this Form 4 transaction?

After the reported restricted stock award, Walter V. Klemp holds 20,118 shares of Autonomix Medical, Inc. Common Stock directly. This total includes the 13,000-share award disclosed in the filing.

What are the vesting terms of the 13,000-share grant reported for AMIX?

The filing states that the 13,000-share grant represents a restricted stock award vesting one-year from the date of issuance of September 3, 2026. The award is therefore subject to a one-year vesting period from that issuance date.

Was the AMIX insider grant to Walter V. Klemp made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is marked in a way that indicates no Rule 10b5-1 trading plan is reported for this transaction. The grant is described as a restricted stock award, not a planned market trade.

Is the AMIX Form 4 transaction a market buy or a compensation award?

The transaction is a compensation-related acquisition. It is coded as a grant, award, or other acquisition of 13,000 shares of Common Stock, rather than an open-market purchase or sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 04:24 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:23 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KLEMP WALTER V

(Last) (First) (Middle)

21 WATERWAY AVENUE

SUITE 300

(Street)

THE WOODLANDS TEXAS 77380

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Autonomix Medical, Inc. [ AMIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/03/2026		A		13,000	A	(1)	20,118	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock award vesting one-year from the date of issuance of September 3, 2026.

	/s/ Trent Smith, Attorney-in-Fact for Walter Klemp	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)